Sage Journals: Discover world-class research

Abstract

Get full access to this article

View all access options for this article.

References

Hurtado

, Maldonado-Lobo

, Díaz-Ropero

, et al. Oral administration to nursing women of Lactobacillus fermentum CECT5716 prevents lactational mastitis development: A randomized controlled trial. Breastfeed Med, 2017; 12:202–209.

Amir

. Academy of Breastfeeding Medicine Protocol Committee. ABM clinical protocol #4: Mastitis, revised March 2014. Breastfeed Med, 2014; 9:239–243.

Delgado

, Arroyo

, Jiménez

, et al. Staphylococcus epidermidis strains isolated from breast milk of women suffering infectious mastitis: Potential virulence traits and resistance to antibiotics. BMC Microbiol, 2009; 9:82.

Biosearch

S.A

. signs a license agreement with Nestlé for its “Lactobacillus fermentum LC40 ®” strain. In: Biosearch Life. News. Updated 2017. Available at www.biosearchlife.es/en/biosearch-s-a-signs-a-license-agreement-with-nestle-for-its-lactobacillus-fermentum-lc40-strain/ (accessed January 10, 2018).

Amir

, Griffin

, Cullinane

, et al.: Probiotics and mastitis: Evidence-based marketing?. Int Breastfeed J, 2016; 11:19.

Re: “Oral Administration to Nursing Women of Lactobacillus fermentum CECT5716 Prevents Lactational Mastitis Development: A Randomized Controlled Trial” by Hurtado et al. ( Breastfeed Med 2017;12:202–209)

Abstract

Get full access to this article

References